Fundz

Navigator Medicines

United States · Biotechnology, Health Care, Therapeutics

Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammat

Key facts

Headquarters
United States
Employees
25
Industries
Biotechnology, Health Care, Therapeutics
Status
Private
Website
www.navigatormedicines.com
LinkedIn
Company page

Recent activity at Navigator Medicines

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Navigator Medicines funding history

DateRoundAmount
Sep 2026Venture$10.0M
Aug 2024Series A$100.0M
Aug 2024Venture$50.0M

Leadership

  • Andrew Levin, Board Member
  • Wouter Joustra, Board Member
  • Dana McClintock, Chief Medical Officer

Verified email and direct lines for Navigator Medicines’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Navigator Medicines in the news

Companies similar to Navigator Medicines

About Navigator Medicines: questions and answers

What does Navigator Medicines do?

Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammat

Where is Navigator Medicines headquartered?

Navigator Medicines is headquartered in United States.

How many employees does Navigator Medicines have?

Navigator Medicines has about 25 employees.

Has Navigator Medicines raised funding?

Yes. Fundz has recorded 3 funding events for Navigator Medicines. The most recent, $10.0M, was in Sep 2026.

What is the latest news on Navigator Medicines?

On Sep 18, 2026, Navigator Medicines

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Navigator Medicines across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.